Trial status (May 2026): Eli Lilly reported positive topline results from the Phase 3 TRIUMPH-1 obesity trial on May 21, 2026, with mean weight reduction of 28.3% at 80 weeks on the 12 mg arm [1][2]
Not every patient needs this, but for patients with significant muscle mass concerns older adults, perimenopausal women, patients losing weight quickly at high doses it is worth considering
Your healthcare provider will have full prescribing information once the drug is launched
Stay current with the latest peptide research developments at Ageless Vitality Peptides, and always ensure your research protocols comply with institutional guidelines and applicable regulations
Risks of Obesity: The Dark Side of the Story Behind the curtain, obesity is a villain with a twisted backstory
These include: decreased libido pain or discomfort during intercourse vaginal dryness Health Risks and Complications Estrogen is healthy for your bodys tissues, including for your heart, bones, urinary system, and more